Consult physician if major illness develops during protocol
McGarrity S, Anuforo O, Halldorsson H, Bergmann A, Halldorsson S, Palsson S, Henriksen HH, Johansson PI, Rolfsson O (2018) Metabolic systems analysis of LPS induced endothelial dysfunction applied to sepsis patient stratification
Co-agonist therapeutics come of age for obesity
Zepbound Outperforms CagriSema in Head-to-Head Phase III Obesity Trial A pivotal Phase III trial has delivered a setback for Novo Nordisk, after its obesity candidate CagriSema was outperformed by Eli Lillys Zepbound (tirzepatide) in a direct comparison study
Glycolic Acid: Removes dead skin delicately, and leads to supple, youthful, and hydrating skin
NAD+ IV Therapy NAD+ is essential for cellular energy production and DNA repair, both severely compromised in long COVID